159 results on '"Vis, M. Marije"'
Search Results
2. A paradox in sex-specific clinical outcomes after bioresorbable scaffold implantation: 2-year results from the AIDA trial
3. Correction: van Veelen et al. First-in-Human Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: Rationale and Design of the DEBuT-LRP Study. J. Clin. Med. 2023, 12, 5807
4. Comparison of Outcomes of Transfemoral Aortic Valve Implantation in Patients 90 Years of Age
5. Incidence, Predictors, and Impact of Vascular Complications After Transfemoral Transcatheter Aortic Valve Implantation With the SAPIEN 3 Prosthesis
6. Procedural Outcome and Midterm Survival of Lower Risk Transfemoral Transcatheter Aortic Valve Implantation Patients Treated With the SAPIEN XT or SAPIEN 3 Device
7. A Randomized Comparison of Paclitaxel-Eluting Balloon Versus Everolimus-Eluting Stent for the Treatment of Any In-Stent Restenosis: The DARE Trial
8. TCT-408 First-in-Human Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: The DEBuT-LRP Study
9. Comparison of Outcome After Percutaneous Mitral Valve Repair With the MitraClip in Patients With Versus Without Atrial Fibrillation
10. Impact of Potentially Malignant Incidental Findings by Computed Tomographic Angiography on Long-Term Survival After Transcatheter Aortic Valve Implantation
11. First-in-Human Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: Rationale and Design of the DEBuT-LRP Study
12. Mitral regurgitation prior to transcatheter aortic valve implantation influences survival but not symptoms
13. Single antiplatelet therapy directly after percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome patients: the OPTICA study
14. Predictors of outcome in patients undergoing MitraClip implantation: An aid to improve patient selection
15. Percutaneous Mitral Valve Repair Preserves Right Ventricular Function
16. Mitral Inflow Patterns after MitraClip Implantation at Rest and during Exercise
17. TCT-85 Periprocedural Cardiac Arrests Significantly Affect Mortality in Cardiogenic Shock Patients Undergoing PCI
18. TCT-17 Single Antiplatelet Therapy Directly After Percutaneous Coronary Intervention in Non–ST-Segment Elevation Acute Coronary Syndrome Patients: The OPTICA Pilot Study
19. Effect of Multivessel Coronary Disease With or Without Concurrent Chronic Total Occlusion on One-Year Mortality in Patients Treated With Primary Percutaneous Coronary Intervention for Cardiogenic Shock
20. Long-term 5-year outcome of the randomized IMPRESS in severe shock trial: percutaneous mechanical circulatory support vs. intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction
21. Cangrelor Use in Routine Practice: A Two-Center Experience
22. DEtection of ProxImal Coronary stenosis in the work-up for Transcatheter aortic valve implantation using CTA (from the DEPICT CTA collaboration)
23. Implementation of CT Coronary Angiography as an Alternative to Invasive Coronary Angiography in the Diagnostic Work-Up of Non-Coronary Cardiac Surgery, Cardiomyopathy, Heart Failure and Ventricular Arrhythmias
24. Clinical outcomes after final kissing balloon inflation compared with no final kissing balloon inflation in bifurcation lesions treated with a dedicated coronary bifurcation stent
25. Clinical outcomes after percutaneous or surgical revascularisation of unprotected left main coronary artery-related acute myocardial infarction: a single-centre experience
26. Late onset of new conduction disturbances requiring permanent pacemaker implantation following TAVI
27. The Impact of Percutaneous Coronary Intervention on Mortality in Patients With Coronary Lesions Who Underwent Transcatheter Aortic Valve Replacement.
28. Transkatheter aortaklepvervanging (TAVI)
29. Late onset of new conduction disturbances requiring permanent pacemaker implantation following TAVI
30. TCT-686 The Impact of Coronary Artery Disease and Pre-Procedural PCI on the Short- and Long-Term Mortality After TAVR
31. TCT-699 Preoperative Frailty Parameters as Predictors for Outcomes After Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis
32. Clinical outcomes at 2 years of the Absorb bioresorbable vascular scaffold versus the Xience drug‐eluting metallic stent in patients presenting with acute coronary syndrome versus stable coronary disease—AIDA trial substudy
33. Comparison of Outcomes of Transfemoral Aortic Valve Implantation in Patients <90 With Those >90 Years of Age
34. 500.02 Clinical Outcomes At 2 Years of The Absorb Bioresorbable Vascular Scaffold Versus The Xience Drug-eluting Metallic Stent In Patients Presenting With Acute Coronary Syndrome Versus Stable Coronary Disease - Aida Trial Sub-study.
35. Corrigendum to ‘Procedural Outcome and Mid-Term Survival of Lower Risk Transfemoral TAVI Patients Treated With The SAPIEN XT or SAPIEN 3 Device’ [American Journal of Cardiology (2018) 856-861]
36. Real-life use of left ventricular circulatory support with Impella in cardiogenic shock after acute myocardial infarction: 12 years AMC experience
37. CT determined psoas muscle area predicts mortality in women undergoing transcatheter aortic valve implantation
38. Guideline-defined futility or patient-reported outcomes to assess treatment success after TAVI: what to use? Results from a prospective cohort study with long-term follow-up
39. Elixhauser Comorbidity Score Is the Best Risk Score in Predicting Survival After Mitraclip Implantation
40. TCT-245 TF-AVI in an ageing population: a single center, retrospective comparison of 47 nonagenarians with 552 patients aged under 90
41. TCT-695 Elixhauser comorbidity score is the best risk score in predicting survival after MitraClip implantation
42. Bioresorbable Scaffolds versus Metallic Stents in Routine PCI
43. Predicting hospitalisation duration after transcatheter aortic valve implantation
44. Clinical outcomes at 2 years of the Absorb bioresorbable vascular scaffold versus the Xience drug‐eluting metallic stent in patients presenting with acute coronary syndrome versus stable coronary disease—AIDA trial substudy.
45. Value of a comprehensive geriatric assessment for predicting one-year outcomes in patients undergoing transcatheter aortic valve implantation: results from the CGA-TAVI multicentre registry.
46. Bioresorbable Scaffolds versus Metallic Stents in Routine PCI.
47. Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction
48. Additional side branch stent placement in patients with long side branch lesions treated with the Tryton dedicated bifurcation side branch stent
49. The IMPACT Study (Influence of Sensor-Equipped Microcatheters on Coronary Hemodynamics and the Accuracy of Physiological Indices of Functional Stenosis Severity)
50. First report on long-term clinical results after treatment of coronary bifurcation lesions with the Tryton dedicated bifurcation stent
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.